Cargando…

Dupilumab‐induced skin‐associated side effects in patients with chronic rhinosinusitis with nasal polyposis

Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a typical type‐2 inflammation involving T‐helper type‐2 cells and impairing quality of life due to nasal obstruction, discharge and reduced sense of smell. Recently, the anti‐IL4Rα antibody dupilumab was approved for CRSwNP. While dermatologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chromy, David, Bartosik, Tina, Brkic, Faris F., Quint, Tamara, Tu, Aldine, Eckl‐Dorna, Julia, Schneider, Sven, Bangert, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091999/ https://www.ncbi.nlm.nih.gov/pubmed/36177732 http://dx.doi.org/10.1111/1346-8138.16595

Ejemplares similares

Platelet-to-lymphocyte ratio might predict the response to dupilumab treatment for patients with nasal polyposis
por: Brkic, Faris F., et al.
Publicado: (2023)

The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
por: Campion, Nicholas J., et al.
Publicado: (2023)

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
por: Schneider, Sven, et al.
Publicado: (2023)

Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease
por: Schneider, Sven, et al.
Publicado: (2020)

Chronic rhinosinusitis symptoms differentially impact the likelihood of major depressive disorders
por: Liu, David T., et al.
Publicado: (2022)

Rhinosinusitis with nasal polyposis
por: Sharma, S.C.
Publicado: (2018)

Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis
por: Jonstam, Karin, et al.
Publicado: (2019)

Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis
por: Tanaka, Shunya, et al.
Publicado: (2022)

The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids
por: Bartosik, Tina J., et al.
Publicado: (2023)

The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)
por: Hardison, Scott A., et al.
Publicado: (2023)

Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study
por: Bertlich, Mattis, et al.
Publicado: (2022)

Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease
por: Bangert, Christine, et al.
Publicado: (2022)

Management of Chronic Rhinosinusitis with Nasal Polyposis in the Era of Biologics
por: C Morse, Justin, et al.
Publicado: (2021)

The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan
por: Fujieda, Shigeharu, et al.
Publicado: (2020)

Characterization of T-cell subpopulations in patients with chronic rhinosinusitis with nasal polyposis
por: Ickrath, Pascal, et al.
Publicado: (2017)

Chronic rhinosinusitis with nasal polyposis: the role of personalized and integrated medicine
por: Passali, Desiderio, et al.
Publicado: (2020)

Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis
por: Lei, Chenyang, et al.
Publicado: (2022)

Remission: does it already exist in chronic rhinosinusitis with nasal polyposis?
por: Chan, Yvonne, et al.
Publicado: (2023)

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps
por: Hellings, Peter W., et al.
Publicado: (2022)

Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis
por: Pelaia, Corrado, et al.
Publicado: (2021)

Change in nasal congestion index after treatment in patients with chronic rhinosinusitis with nasal polyposis
por: Sahin-Onder, Serap, et al.
Publicado: (2016)

Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis
por: Grzanka, Alicja, et al.
Publicado: (2010)

Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
por: Kang, Suzie Hyeona, et al.
Publicado: (2015)

A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes
por: Dennis, Steven K., et al.
Publicado: (2016)

Considerations for the Use of Biologic Agents in Patients With Chronic Rhinosinusitis With Nasal Polyposis
por: Kim, Do Hyun, et al.
Publicado: (2021)

Considerations for the Use of Biologic Agents in Patients With Chronic Rhinosinusitis With Nasal Polyposis
por: Kim, Do Hyun, et al.
Publicado: (2021)

The role of Staphylococcus aureus enterotoxin B in chronic rhinosinusitis with nasal polyposis
por: Chegini, Zahra, et al.
Publicado: (2022)

Impact of Chronic Rhinosinusitis with Nasal Polyposis on IL-12 and IL-8
por: do Amaral, Janatas Bussador, et al.
Publicado: (2023)

Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis
por: Giombi, Francesco, et al.
Publicado: (2022)

The Effect of Corticosteroids on Sinus Microbiota in Chronic Rhinosinusitis Patients with Nasal Polyposis
por: Alammar, Yousif, et al.
Publicado: (2023)

Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series
por: Bosma, A. L., et al.
Publicado: (2021)

Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
por: Kim, Jean, et al.
Publicado: (2020)

AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
por: Siddiqui, Shahid, et al.
Publicado: (2022)

Differences in men and women suffering from CRSwNP and AERD in quality of life
por: Bartosik, Tina J., et al.
Publicado: (2020)

Apoptosis factors caspases and p53 and their impact in chronic rhinosinusitis with nasal polyposis
por: Valera, Fabiana, et al.
Publicado: (2013)

Inflammatory cell predominance and patterns in chronic rhinosinusitis with and without nasal polyposis patients
por: Marino, Michael J., et al.
Publicado: (2019)

Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review
por: Nitro, Letizia, et al.
Publicado: (2022)

Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps
por: Gevaert, Philippe, et al.
Publicado: (2023)

Dupilumab's Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
por: Loperfido, Antonella, et al.
Publicado: (2023)

IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis
por: Park, Soo-Kyoung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6kkl521ga7qkdhv366hnmop6mt